# APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

> **NCT05550961** · — · RECRUITING · sponsor: **Fondazione IRCCS Istituto Nazionale dei Tumori, Milano** · enrollment: 1200 (estimated)

## Conditions studied

- NSCLC
- Cancer
- Lung Cancer
- Adenocarcinoma of Lung
- Squamous Cell Lung Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05550961
- **Lead sponsor:** Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2027-10-01
- **Final completion:** 2032-10-01
- **Target enrollment:** 1200 (ESTIMATED)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05550961

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05550961, "APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05550961. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*